Condition: Vulvovaginal Candidiasis · Candida Infection · Vaginal Candidiasis · Sponsor: Scynexis, Inc.
This is an ongoing evaluation of subjects exposed to ibrexafungerp while pregnant. The study population will include pregnant women of any age.
This description comes directly from the study's public registry record.
Sanjeev Miglani, MD · +91-9910533655 · sanjeev.miglani@awinsals.com
Always discuss trial participation with your own doctor first.
| AWINSA | New Delhi, Vasant Vihar, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05908682